Answered

Discover the answers you need at Westonci.ca, where experts provide clear and concise information on various topics. Connect with professionals on our platform to receive accurate answers to your questions quickly and efficiently. Get immediate and reliable solutions to your questions from a community of experienced professionals on our platform.

Which of the following direct factor Xa Inhibitors is used in combination with aspirin to reduce cardiovascular events in patients with chronic coronary artery disease (CAD) or peripheral artery disease?
a, Rivaroxaban
b. Apixaban
c. Edoxaban

Sagot :

Thanks for using our platform. We aim to provide accurate and up-to-date answers to all your queries. Come back soon. We appreciate your time. Please come back anytime for the latest information and answers to your questions. Thank you for visiting Westonci.ca. Stay informed by coming back for more detailed answers.